18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Conditions: Breast Cancer; Breast Neoplasms; Breast Diseases Interventions: Diagnostic Test: 68Ga-FAPI-46 PET/CT and 68Ga-FAPI-46 PET/MRI Sponsors: Maastricht University Medical Center Not yet recruiting

https://clinicaltrials.gov/study/NCT06335069

Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials

More News: Breast Cancer | Cancer | Cancer & Oncology | Research